Dr. Muhammad Y. Ebrahim, MD
Nephrology (Kidney) (Nephrology Physician)
322 N Pine St
Spartanburg, SC 29302
Who else practices at this address →
Spartanburg County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 35
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 618
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
SC license SC20986
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Spartanburg Medical Center Spartanburg, SC
- Pelham Medical Center Greer, SC
- Cherokee Medical Center Gaffney, SC
- Union Medical Center Union, SC
Medical groups
- Nephrology Associates of Spartanburg LLC (8 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 618
- Services billed
- 2,478
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 880 | 404 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 338 | 131 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 205 | 125 |
| New patient office or other outpatient visit, 45-59 minutes | 96 | 96 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 56 | 45 |
| Hemodialysis procedure with physician evaluation | 40 | 27 |
| Established patient office or other outpatient visit, 40-54 minutes | 39 | 32 |
| Established patient office or other outpatient visit, 20-29 minutes | 28 | 27 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 23 | 23 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 21 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Farxiga (dapagliflozin propanediol) Other prescribers in Spartanburg, SC | 436 |
| Prazosin Hcl Other prescribers in Spartanburg, SC | 371 |
| Jardiance (empagliflozin) Other prescribers in Spartanburg, SC | 210 |
| Nebivolol Hcl Other prescribers in Spartanburg, SC | 191 |
| Kerendia (finerenone) Other prescribers in Spartanburg, SC | 190 |
| Bumetanide Other prescribers in Spartanburg, SC | 184 |
| Spironolactone Other prescribers in Spartanburg, SC | 171 |
| Carvedilol Other prescribers in Spartanburg, SC | 148 |
| Amlodipine Besylate Other prescribers in Spartanburg, SC | 146 |
| Potassium Chloride Other prescribers in Spartanburg, SC | 103 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 20 companies reported 100 payments worth $1,740 in total to this clinician.
| Travere Therapeutics, Inc. | $272 |
|---|---|
| Otsuka America Pharmaceutical, Inc. | $217 |
| Calliditas Therapeutics US Inc. | $197 |
| Novartis Pharmaceuticals Corporation | $124 |
| Bayer HealthCare Pharmaceuticals Inc. | $118 |
| Amgen Inc. | $117 |
| Akebia Therapeutics Inc | $87.94 |
| AstraZeneca Pharmaceuticals LP | $78.18 |
| Food and Beverage | $1,699 |
|---|---|
| Education | $40.92 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Opko Pharmaceuticals, LLC Nov 11, 2025 | Education RAYALDEE · NEPHROLOGY · in-kind | $21.34 |
| Opko Pharmaceuticals, LLC Aug 28, 2025 | Education RAYALDEE · NEPHROLOGY · in-kind | $19.58 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $28,367 in research payments for these studies, mostly to the institutions running them.
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Csl Behring · Recruiting · NCT05485961
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.